help button home button Endocrine Society Endocrinology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Goodman, H. M.
Right arrow Articles by Grichting, G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Goodman, H. M.
Right arrow Articles by Grichting, G.

Endocrinology, Vol 113, 1697-1702, Copyright © 1983 by Endocrine Society


ARTICLES

Growth hormone and lipolysis: a reevaluation

HM Goodman and G Grichting

A recent report claimed that the lipolytic activity found in clinical grade human GH (hGH) was entirely attributable to an acidic peptide contaminant. Using the same preparations as studied in the earlier report, we found that delayed lipolytic activity, as demonstrated in the presence of dexamethasone, was fully evident in the highly purified hGH preparation which had been reported to be devoid of lipolytic activity. We also studied the acidic peptide contaminant in which all of the lipolytic activity of clinical grade hGH was alleged to reside and found its lipolytic activity was equivalent to that of the highly purified hGH. Both compounds increased lipolysis in the presence of 0.1 micrograms/ml dexamethasone after a lag period of 1 h. The minimum effective concentration of both fell within the range of 1 and 10 ng/ml, and both were capable of producing a 2- to 3-fold increase in glycerol production. When saturating amounts of each were added simultaneously they produced no greater effect than either alone, although the lipolytic rate was far from saturated as evidenced by the more than 2-fold further increase in glycerol production when 100 ng/ml epinephrine was added along with the combined peptides. The lipolytic response to highly purified hGH was comparable to that seen with bacterially synthesized hGH which should be free of pituitary peptide contaminants. The acidic peptide appeared to be a variant of hGH as judged by its ability to produce both an insulin-like response and refractoriness. Furthermore, the acidic peptide was indistinguishable from hGH in competing for specific binding sites on adipocytes. Although an ability to increase glycerol production in rat adipose tissue in vitro thus appears to be an intrinsic property of hGH, the physiological significance of this effect remains to be established.


This article has been cited by other articles:


Home page
J. Clin. Endocrinol. Metab.Home page
M. Misra, J. Cord, R. Prabhakaran, K. K. Miller, and A. Klibanski
Growth Hormone Suppression after an Oral Glucose Load in Children
J. Clin. Endocrinol. Metab., December 1, 2007; 92(12): 4623 - 4629.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
R. G.-C. Yip and H. M. Goodman
Growth Hormone and Dexamethasone Stimulate Lipolysis and Activate Adenylyl Cyclase in Rat Adipocytes by Selectively Shifting Gi{alpha}2 to Lower Density Membrane Fractions
Endocrinology, March 1, 1999; 140(3): 1219 - 1227.
[Abstract] [Full Text]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 1983 by The Endocrine Society